SCHEDULE 13G
Statement of Beneficial Ownership
Avalo Therapeutics, Inc. Filed Acc 0001493152-26-049273
Stakes reported in this filing
Stake history · largest stake in each 13D and 13G
Loading xslSCHEDULE_13G_X02/primary_doc.xml…